This article provides a comprehensive comparison of X-ray crystallography and cryo-electron microscopy (cryo-EM) for determining the structures of complex biological macromolecules.
Accurate prediction of protein-ligand binding poses is crucial for structure-based drug design but remains challenging due to limitations in sampling algorithms, scoring functions, and data biases.
Weak protein-small molecule interactions (KD > 10⁻⁴ M) are increasingly recognized as crucial regulators of biochemical pathways, allosteric regulation, and signaling cascades, yet they present significant challenges for characterization and...
Targeting protein-protein interactions (PPIs) and designing novel protein functions often requires addressing the challenge of limited binding pockets.
Obtaining high-quality crystals of protein-ligand complexes is a critical yet often limiting step in structural biology and rational drug design.
This article provides a comprehensive resource for researchers and drug development professionals aiming to improve the specificity of protein-protein interaction (PPI) hotspot prediction.
This article provides a comprehensive analysis for drug development professionals on navigating Lipinski's Rule of Five violations in Protein-Protein Interaction (PPI) modulator candidates.
Targeting shallow protein surfaces represents a major frontier in drug discovery, crucial for addressing historically 'undruggable' targets like those involved in protein-protein interactions.
Protein-protein interactions (PPIs), once dismissed as 'undruggable' due to their large, flat, and hydrophobic interfaces, are now being successfully targeted thanks to a paradigm shift in drug discovery.
Hydrogen/deuterium exchange mass spectrometry (HDX-MS) has emerged as a powerful biophysical technique for studying protein structure and dynamics, providing critical insights into protein-ligand interactions that drive modern drug discovery.